June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
The Economic Cost of Myopia in Singapore
Author Affiliations & Notes
  • Seang-Mei Saw
    Saw Swee Hock School of Public Health, National Univ of Singapore, Singapore, Singapore
    Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore, Singapore
  • Yingfeng Zheng
    Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore, Singapore
  • Junxing Chay
    HSSR, Duke-NUS Graduate Medical School, Singapore, Singapore
  • Chen Wei Pan
    Saw Swee Hock School of Public Health, National Univ of Singapore, Singapore, Singapore
  • Ecosse Lamoureux
    Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore, Singapore
    HSSR, Duke-NUS Graduate Medical School, Singapore, Singapore
  • Eric Finkelstein
    Saw Swee Hock School of Public Health, National Univ of Singapore, Singapore, Singapore
    HSSR, Duke-NUS Graduate Medical School, Singapore, Singapore
  • Tien Wong
    Singapore Eye Research Institute, Singapore Eye Research Institute, Singapore, Singapore
    Ophthalmology, National University Health System, National University of Singapore, Singapore, Singapore
  • Footnotes
    Commercial Relationships Seang-Mei Saw, None; Yingfeng Zheng, None; Junxing Chay, None; Chen Wei Pan, None; Ecosse Lamoureux, None; Eric Finkelstein, None; Tien Wong, Allergan (C), Bayer (C), Novartis (C), Pfizer (C), GSK (F), Roche (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5711. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Seang-Mei Saw, Yingfeng Zheng, Junxing Chay, Chen Wei Pan, Ecosse Lamoureux, Eric Finkelstein, Tien Wong; The Economic Cost of Myopia in Singapore. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5711.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To estimate the economic cost of myopia in Singapore.

Methods: A sub study of 113 Singaporean adults aged 40 and above with myopia (spherical equivalent refraction (SE) of at least -0.5D) in the population-based ancillary study of Singapore Chinese Eye Study (SCES) was conducted. A health expenditure questionnaire included the cost of each optometrist visit, spectacles, contact lenses, laser refractive surgery and associated complications, and management of pathologic myopic complications. The economic burden of treatment of myopia was extrapolated to Singapore using data from the national census and prevalence data from epidemiologic studies.

Results: A total of 113 out of 125 myopic subjects (90.4%) participated in the survey. The mean cost was approximately SGD$900 (USD$709) per person per year. The lifetime per capita cost ranged from SGD$295 (USD$232) for those with 0 years duration to SGD$21,616 (USD$17,020) for those with 80 years duration. Costs of spectacles, contact lenses and optometry services were the major cost drivers, contributing to an average of 65% of total costs. Seven subjects (6.2%) had undergone Lasik surgery, resulting in a cost of SGD$4,891 (USD$3,851) per patient per year. Three subjects (2.7%) reported annual costs of (SGD$33 or USD$26) for complications due to Lasik surgery or contact lenses. There was an increasing cost of myopia in adults who started to wear glasses at earlier ages. By applying our cost data to age-specific myopia prevalence data in the whole population in the country, the total cost was estimated to be approximately SGD$959 (USD$755) million per year in Singapore.

Conclusions: Our study shows that myopia is associated with substantial out of pocket expenditure, imposing considerable economic burden for patients. Myopia is a disease with immense societal costs and public health impact.

Keywords: 605 myopia • 460 clinical (human) or epidemiologic studies: health care delivery/economics/manpower • 676 refraction  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×